BRUJX
Price
$16.49
Change
+$0.06 (+0.37%)
Updated
Aug 19 closing price
Net Assets
305.83M
VVIAX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

BRUJX vs VVIAX

Header iconBRUJX vs VVIAX Comparison
Open Charts BRUJX vs VVIAXBanner chart's image
MFS Blended Research Value Equity R1
Price$16.49
Change+$0.06 (+0.37%)
VolumeN/A
Net Assets305.83M
Vanguard Value Index Adm
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
BRUJX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRUJX vs. VVIAX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUJX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. BRUJX (306M). VVIAX pays higher dividends than BRUJX: VVIAX (2.18) vs BRUJX (1.37). BRUJX was incepted earlier than VVIAX: BRUJX (10 years) vs VVIAX (25 years). BRUJX (1.60) is less costly to investors than VVIAX (0.05). BRUJX is a more actively managed with annual turnover of: 55.00 vs. VVIAX (9.00). BRUJX has a lower initial minimum investment than VVIAX: BRUJX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.59 vs. BRUJX (0.68). VVIAX return over 5 years is better than : 70.19 vs. BRUJX (43.67).
BRUJXVVIAXBRUJX / VVIAX
Total Expense Ratio1.490.052,980%
Annual Report Gross Expense Ratio1.600.053,200%
Fund Existence10 years25 years-
Gain YTD8.7366.532134%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets306M196B0%
Annual Yield % from dividends1.372.1863%
Returns for 1 year0.687.599%
Returns for 3 years14.6127.0354%
Returns for 5 years43.6770.1962%
Returns for 10 yearsN/A127.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA6.160.20
+3.27%
Verrica Pharmaceuticals Inc
ARCB71.830.37
+0.52%
ArcBest Corp
FVNNU10.50-0.04
-0.38%
Future Vision II Acquisition Corp.
AM17.55-0.36
-2.01%
Antero Midstream Corp
CAPR7.70-0.27
-3.39%
Capricor Therapeutics